Free Trial

Ikena Oncology (IKNA) SEC Filings & 10K Form

Ikena Oncology logo
$1.72
+0.01 (+0.58%)
(As of 11/1/2024 ET)

Recent Ikena Oncology SEC Filings

DateFilerForm TypeView
05/28/2024
3:24 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:33 PM
Ikena Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:22 PM
Ikena Oncology (Filer)
Form DEF 14A
03/12/2024
6:48 AM
Ikena Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2024
6:30 AM
Ikena Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2024
7:19 AM
FMR LLC (Filed by)
Ikena Oncology (Subject)
Form SC 13G/A
02/21/2024
3:29 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
Ikena Oncology (Subject)
Form SC 13G/A
02/14/2024
8:47 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Ikena Oncology (Subject)
Form SC 13G/A
02/09/2024
8:16 AM
Ikena Oncology (Subject)
Form SC 13G/A
02/02/2024
4:15 PM
Ecsedy Jeffrey (Reporting)
Ikena Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:07 PM
Ikena Oncology (Issuer)
Manfredi Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:08 PM
Ikena Oncology (Issuer)
Marango Jotin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:26 PM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:09 AM
Ikena Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:30 AM
Ikena Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IKNA) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners